First report on clinical features of Mycoplasma pneumoniae infections in Vietnamese children

被引:0
作者
Huong, Phan L. T.
Thi, Ngo T.
Nguyet, Nguyen T. T.
Van, Ta K.
Hang, Dang T.
Huong, Vu T. T.
Anh, Dang D.
Sasaki, Tsuguo
机构
[1] Natl Inst Hyg & Epidemiol, Dept Bacteriol, Hanoi, Vietnam
[2] Natl Hosp Pediat, Hanoi, Vietnam
[3] Natl Inst Infect Dis, Tokyo 2080011, Japan
关键词
D O I
暂无
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Mycoplasma pneumoniae is a common cause of community-acquired pneumonia (CAP) in children, but there has been no clinical report on M. pneumoniae infections in Vietnamese children. We investigated the clinical features of M. pneumoniae infection when the pathogen was detected in the respiratory tract in hospitalized children aged 1-15 years due to lower respiratory tract infections or CAP in Vietnamese children. Throat swabs from 47 patients (18.6%) of 252 patients with a clinical diagnosis of CAP were PCR positive (male, 34; female, 13), and 21 throat swabs (8.3%) showed culture positive for M. pneumoniae. The M. pneumoniae pathogen could be detected by PCR and/or culture in 52 patients (male, 36; female, 16). The major clinical signs in the 52 patients were fever (> 38 degrees C) in 100%, pharyngitis in 100%, tachypnea in 94%, dry cough in 86.5%, and rough breathing in 83% of patients. The average term of illness prior to hospitalization was 7.5 +/- 4.1 days, and the average number of hospitalized days was 7.9 +/- 3.5 days. beta-lactam group antibiotics, which were ineffective against M. pneumoniae infection, were used in 3 7 cases (71%).
引用
收藏
页码:370 / 373
页数:4
相关论文
共 20 条
  • [11] KENRI T, 2000, JPN J MYCOPLASMOL, V27, P20
  • [12] Krause DC, 2001, FEMS MICROBIOL LETT, V198, P1, DOI 10.1111/j.1574-6968.2001.tb10610.x
  • [13] Characterization and molecular analysis of macrolide-resistant Mycoplasma pneumoniae clinical isolates obtained in Japan
    Matsuoka, M
    Narita, M
    Okazaki, N
    Ohya, H
    Yamazaki, T
    Ouchi, K
    Suzuki, I
    Andoh, T
    Kenri, T
    Sasaki, Y
    Horino, A
    Shintani, M
    Arakawa, Y
    Sasaki, T
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (12) : 4624 - 4630
  • [14] *NAT I INF DIS TUB, 2007, JAPAN INFECT AGENTS, V28, P31
  • [15] Principi Nicola, 2001, Clinical Infectious Diseases, V32, P1281, DOI 10.1086/319981
  • [16] QUY T, 1994, PEDIAT MONOGRAPHS, P324
  • [17] Epidemiological study of Mycoplasma pneumoniae infections in Japan based on PCR-restriction fragment length polymorphism of the P1 cytadhesin gene
    Sasaki, T
    Kenri, T
    Okazaki, N
    Iseki, M
    Yamashita, R
    Shintani, M
    Sasaki, Y
    Yayoshi, M
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1996, 34 (02) : 447 - 449
  • [18] SEQUENCE DIVERGENCY OF THE CYTADHESIN GENE OF MYCOPLASMA-PNEUMONIAE
    SU, CJ
    CHAVOYA, A
    DALLO, SF
    BASEMAN, JB
    [J]. INFECTION AND IMMUNITY, 1990, 58 (08) : 2669 - 2674
  • [19] Clinical evaluation of macrolide-resistant Mycoplasma pneumoniae
    Suzuki, S
    Yamazaki, T
    Narita, M
    Okazaki, N
    Suzuki, I
    Andoh, T
    Matsuoka, M
    Kenri, T
    Arakawa, Y
    Sasaki, T
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (02) : 709 - 712
  • [20] Comparison of PCR for sputum samples obtained by induced cough and serological tests for diagnosis of Mycoplasma pneumoniae infection in children
    Yamazaki, Tsutornu
    Narita, Mitsuo
    Sasaki, Nozoniii
    Kenri, Tsuyoshi
    Arakawa, Yoshichika
    Sasaki, Tsuguo
    [J]. CLINICAL AND VACCINE IMMUNOLOGY, 2006, 13 (06) : 708 - 710